PETER WOLFF: Open Payments
NPI 1720554884 · LANCASTER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 15 payments from 7 companies in 2025. Trend: 2023 $263 · 2024 $610 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 4 | $99 |
| Amgen Inc. | 3 | $76 |
| ABBVIE INC. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: Zoryve, OTEZLA, SKYRIZI, Sotyktu, DUPIXENT, AKLIEF, COSENTYX, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
